Abstract
This literature review presents findings on various aspects of concurrent bronchial asthma and COVI D -1 9. In particular, it discusses issues of bronchial asthma incidence among patients with confirmed COVI D -1 9, the influence of bronchial asthma on the risk of the new coronavirus infection, and the specific course of bronchial asthma in COVI D -1 9 patients. It considers the use of individual components of basic asthma therapy during the pandemic, in particular, inhaled and systemic corticosteroids, antileukotriene drugs, and targeted therapy. The article pays attention to recommendations for the choice of inhalation devices in light of prevention of the new coronavirus infection spread.
Highlights
В обзоре литературы приводятся результаты исследований, посвященных различным аспектам сочетания бронхиальной астмы и COVID-19
This literature review presents findings on various aspects of concurrent bronchial asthma and COVID-19. It discusses issues of bronchial asthma incidence among patients with confirmed COVID-19, the influence of bronchial asthma on the risk of the new coronavirus infection, and the specific course of bronchial asthma in COVID-19 patients. It considers the use of individual components of basic asthma therapy during the pandemic, in particular, inhaled and systemic corticosteroids, antileukotriene drugs, and targeted therapy
D. et al сопутствующая бронхиальной астмы (БА) обнаружена у 220 (14%) из 1 526 пациентов с COVID-19, подтвержденным методом полимеразной цепной реакции (ПЦР)
Summary
В обзоре литературы приводятся результаты исследований, посвященных различным аспектам сочетания бронхиальной астмы и COVID-19. В условиях пандемии COVID-19 (COronaVIrus Disease 2019) врачи столкнулись с трудностями диагностики и лечения заболеваний дыхательной системы, в том числе бронхиальной астмы (БА) [1, 14, 16, 36, 37], которой страдают более 300 млн пациентов во всем мире [32]. Проведенных за пределами Китая, результаты которых описаны ниже, показана более высокая распространенность БА среди пациентов с подтвержденным COVID-19.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.